Lifeward (LFWD) Shareholder's Equity (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Lifeward | 5.59 Mn | -5.81 Mn | 1.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.18% |
| Dec 31, 2025 | -34.08% |
| Sep 30, 2025 | -15.59% |
| Jun 30, 2025 | -18.13% |
| Mar 31, 2025 | -2.08% |
| Dec 31, 2024 | -44.39% |
| Sep 30, 2024 | -7.62% |
| Jun 30, 2024 | -9.67% |
| Mar 31, 2024 | -12.67% |
| Dec 31, 2023 | -10.17% |
| Sep 30, 2023 | -12.21% |
| Jun 30, 2023 | -7.16% |
| Mar 31, 2023 | -6.82% |
| Dec 31, 2022 | -9.82% |
| Sep 30, 2022 | -6.58% |
| Jun 30, 2022 | -5.02% |
| Mar 31, 2022 | -4.70% |
| Dec 31, 2021 | -3.88% |
| Sep 30, 2021 | 40.73% |
| Jun 30, 2021 | -4.26% |
| Mar 31, 2021 | 216.98% |
| Dec 31, 2020 | 29.69% |
| Sep 30, 2020 | 41.10% |
| Jun 30, 2020 | -9.05% |
| Mar 31, 2020 | 21.36% |
| Dec 31, 2019 | -23.63% |
| Sep 30, 2019 | -18.26% |
| Jun 30, 2019 | 740.29% |
| Mar 31, 2019 | 5.66% |
| Dec 31, 2018 | 137.25% |
| Sep 30, 2018 | -313.05% |
| Jun 30, 2018 | 15.68% |
| Mar 31, 2018 | -140.44% |
| Dec 31, 2017 | 176.64% |
| Sep 30, 2017 | -60.62% |
| Jun 30, 2017 | 1.83% |
| Mar 31, 2017 | -59.54% |
| Dec 31, 2016 | 75.67% |
| Sep 30, 2016 | -41.59% |
| Jun 30, 2016 | -49.42% |
| Mar 31, 2016 | -23.93% |